ロード中...
Orphan drugs: Unmet societal need for non-profitable privately supplied new products
Due to the severity of rare diseases, the societal need for biopharmaceutical treatments for these diseases is high, despite low numbers of patients. Therefore, we investigated the barriers currently hindering the willingness to develop orphan drugs in the Netherlands. To this end, a robust, small s...
保存先:
| 出版年: | Res Policy |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier B.V.
2007
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7112095/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.respol.2006.12.006 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|